U.S. DOCTOR SURVIVES EBOLA - Treated with Experimental ZMapp Drug & Released from Hospital

To evaluate the condition of Dr. Kent Brantly, the American aid worker who became the first person to be treated for Ebola in the United States, all anyone needed to do Thursday was notice what he was not wearing.

Gone was the bulky white suit he wore when he arrived Aug. 2, amid heavy security, at Emory University Hospital here.

Instead, appearing trim and vibrant and wearing a button-down shirt and slacks, Dr. Brantly stood before reporters as he prepared to leave Emory after his doctors declared him recovered from the virus he contracted while working in Liberia.

“Today is a miraculous day,” Dr. Brantly, his wife at his side, said in a steady voice that wavered when he thanked his health care team. “I am thrilled to be alive, to be well and to be reunited with my family.”
Continue reading the main story
Related Coverage Clashes Erupt as Liberia Sets an Ebola QuarantineAUG. 20, 2014 United Nations health workers in New Kru Town, Liberia. Residents are being urged to wash their hands to help prevent the spread of the epidemic. Ebola Death Toll in West Africa Tops 1,200AUG. 19, 2014 Nancy Writebol, a missionary infected with the Ebola virus, was taken to Emory University Hospital in Atlanta on Tuesday. Atlanta Hospital Admits Second American With EbolaAUG. 5, 2014

Emory said on Thursday that Dr. Brantly, who lived in Fort Worth before going to Liberia, and Nancy Writebol, a missionary from Charlotte, N.C., who also contracted Ebola while in Africa this summer, had been released from its specialized isolation unit this week. The hospital, in a statement, said it was “confident that the discharge of these patients poses no public health threat” and said the decision to release them was linked to the results of urine and blood tests.

Dr. Kent Brantly of Texas was given ZMapp, a drug used on a handful of patients in the West African outbreak and produced by U.S.-based Mapp Biopharmaceutical.

Brantly, 33, is expected to speak at a news conference on Thursday at Emory University Hospital, where he and U.S. missionary Nancy Writebol have been treated since being evacuated from Liberia earlier this month.

Former US congressman Ron Paul says governments deceive people over the threat of the Ebola virus, although it is a very, very serious illness.

The physician offered the chemical DDT as a “viable alternative for treatment,” Voices of Liberty reported Another government ruse to get us to panic and spend our money on useless vaccinations? National Assembly member Patrick Balkany claims that the Ebola virus has hit France, but his comments were quickly denied by the country’s health authorities. It’s an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories.

Using plants this way — sometimes called “pharming” — can produce complex and valuable proteins for medicines. That approach, studied for about 20 years, hasn’t caught on widely in the pharmaceutical industry.

But some companies and academic labs are pursuing it to create medicines and vaccines against such targets as HIV, cancer, the deadly Marburg virus and norovirus, known for causing outbreaks of stomach bug on cruise ships, as well as Ebola. The Ebola virus is spreading and no one in any position of authority is releasing information to the public about how serious of a contagion this is.

It was just a few weeks ago that the CDC and mainstream media claimed it wouldn’t make it to U.S. shores, but as of this morning, reports are flowing in from all over the country from hospitals that have admitted patients who recently traveled to Africa and are showing possible symptoms of the deadly virus.

In Nigeria, where there have only been a couple of deaths reported officially, the medical community has formally requested help in the form of experimental serums from the United States, suggesting things are much worse there than are being reported.